Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model. [electronic resource]
Producer: 20171227Description: 2314-2319 p. digitalISSN:- 1097-4644
- Aged
- Animals
- Azetidines -- therapeutic use
- Cell Line, Tumor
- Disease Models, Animal
- Female
- Humans
- Indoles -- therapeutic use
- Melanoma -- drug therapy
- Mice
- Mice, Nude
- Microscopy, Confocal
- Microscopy, Electron, Transmission
- Mutation -- genetics
- Piperidines -- therapeutic use
- Proto-Oncogene Proteins B-raf -- genetics
- Pyridones -- therapeutic use
- Pyrimidinones -- therapeutic use
- Salmonella typhimurium -- genetics
- Sulfonamides -- therapeutic use
- Vemurafenib
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.